HONG KONG, 23 September 2021 – Lianhe Ratings Global Limited (“Lianhe Global”), an international credit rating company, has assigned ‘BBB-’ global scale Long-term Issuer Credit Rating to Taizhou Huaxin Pharmaceutical Investment Co., Ltd. (“THPI”). The Outlook is Stable.